Most popular articles on this site Articles on pharmacy Articles on capitation Articles on disease management

www managedcaremag.com
Click Here



NOW AVAILABLE
The next generation in online publishing...


Sign up to read the digital versions of Managed Care, P&T, and Biotechnology Healthcare. These digital editions are free, searchable, and can be downloaded and read offline. To read a sample of the digital version of Managed Care, follow this link:

> Sample digital edition

> Register for a free digital subscription

Archive issues of Managed Care:


MANAGED CARE September 2004. ©MediMedia USA

Vol. 13, No. 9
September 2004

Cover Story

'May You Live in Interesting Times'

The health care industry, doing well today, may be in for some interesting times, a euphemism for big-time trouble. Have rising costs brought us to yet another watershed?

Straight Talk From Margaret E. O'Kane

The head of the NCQA likes pay for performance. "We're paying for bad quality now, and that bad quality often costs more."

Be a CAM-Do Health Plan

That's the advice of the consultant Sherrie Dulworth, RN, of Milliman USA. CAM can be good therapy and good business.

Guidelines Can Bend Without Breaking

HMOs need to change their attitude toward what are supposed to be tools for doctors, not rules chiseled in stone.

Fill Your Conferences and Workshops

Here's what one MCO learned about how to recruit for educational seminars: Let the medical director issue the invitation.

Taking Stock of Illness on the Clock

Employers are looking into presenteeism, when workers are on the job but not functioning at 100 percent. Can plans help?

DEPARTMENTS

Editor's Memo

Big and small business cry "Crisis!"

Legislation and Regulation

Pfizer: We did well by Fla. Medicaid.

News and Commentary

VA Beats Managed Care In Treatment of Diabetes
Bush officials seek bounce from Medicare reform law [chart]
Headlines on Deadline

Formulary Files

Heart meds underuse means trouble.

Compensation Monitor

Four favored specialties prosper.

Tomorrow's Medicine

Orphan drugs deserve coverage.

Outlook

Employers skeptical about CDHC.